Article révisé par les pairs
Résumé : This paper compares corporate and academic patents and tests whether they have similar value distributions and share common determinants of value. The empirical results based on an in-depth analysis of 400 biotech patents applied for by Belgian universities and firms lead to the following observations: (i) academic and corporate patent value distributions have similar levels of 'skewness'; (ii) the identification of the institutional origin of knowledge allows for an improved understanding of the value determinants and (iii) there is a need to stimulate star scientists to codify their tacit knowledge into valuable patents. © 2006 Elsevier B.V. All rights reserved.